ND SB2370

Legislative management must conduct a study during the 2025-26 interim on establishing reporting requirements for entities participating in the federal 340B drug discount program (42 U.S.C. 256b) in North Dakota

Study must evaluate which entities should report data, including hospitals, contract pharmacies, federally qualified health centers, drug manufacturers, pharmacy benefits managers, and health insurers

Required analysis includes specific data elements to report, methods for compiling and sharing data, confidentiality issues, and enforcement mechanisms including civil penalties

Consultation required with 12 stakeholder groups including hospital associations, pharmacy associations, the insurance department, department of health and human services, and the board of pharmacy

Findings and recommendations with any implementing legislation must be reported to the 70th Legislative Assembly; passed Senate 40-5 and House 77-12